Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
3,838,602,439
-
Total 13F shares
-
131,231
-
Share change
-
+19,404
-
Total reported value
-
$193,878
-
Price per share
-
$1.48
-
Number of holders
-
13
-
Value change
-
+$24,967
-
Number of buys
-
6
-
Number of sells
-
5
Institutional Holders of Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF) as of Q1 2025
As of 31 Mar 2025,
Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
131,231 shares.
The largest 10 holders included
RHUMBLINE ADVISERS, MORGAN STANLEY, BNP PARIBAS FINANCIAL MARKETS, XTX Topco Ltd, Virtu Financial LLC, CAPTRUST FINANCIAL ADVISORS, FIFTH THIRD BANCORP, WELLS FARGO & COMPANY/MN, Costello Asset Management, INC, and NATIONAL BANK OF CANADA /FI/.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.